Chinook Therapeutics, Inc.

BAILLIE GIFFORD & CO

Report date

6/30/2023

Quarter

2023 Q2

Filed

7/28/2023

Shares

463,945

Value ($000)

17,825

Weight

0.0%

2020 Q3 - 2023 Q2 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	7/28/2023	17,825	0.0%	463,945	6/30/2023
2023 Q1	5/3/2023	11,265	0.0%	486,595	3/31/2023
2022 Q4	3/10/2023	12,830	0.0%	489,708	12/31/2022
2022 Q3	10/27/2022	9,128	0.0%	464,314	9/30/2022
2022 Q2	8/8/2022	8,829	0.0%	504,825	6/30/2022
2022 Q1	5/5/2022	13,266	0.0%	810,879	3/31/2022
2021 Q4	1/20/2022	13,762	0.0%	843,812	12/31/2021
2021 Q3	10/19/2021	10,688	0.0%	837,576	9/30/2021
2021 Q2	8/2/2021	11,852	0.0%	839,380	6/30/2021
2021 Q1	5/6/2021	13,139	0.0%	845,485	3/31/2021
2020 Q4	2/10/2021	13,397	0.0%	844,684	12/31/2020
2020 Q3	11/12/2020	10,366	0.0%	4,265,980	9/30/2020